Please enable JavaScript to continue using this application.

Compare $CLCS vs $TVGN | Chartloom

Compare

$CLCS vs $TVGN

Cell Source Inc · Tevogen Bio Holdings Inc

CLCS

Cell Source Inc

TVGN

Tevogen Bio Holdings Inc

Compare $CLCS vs $TVGN

Comparing Cell Source Inc and Tevogen Bio Holdings Inc

CLCSCell Source Inc

TVGNTevogen Bio Holdings Inc

CLCSCell Source Inc

Market cap

$37M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-9.1%

52W performance

76.1%

FCF yield

-8.4%

TVGNTevogen Bio Holdings Inc

Market cap

$29M

P/E (TTM)

6.23x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.7%

52W performance

-81.7%

FCF yield

-2.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLCS

TVGN

Detailed metrics comparison

CLCS

Cell Source Inc

TVGN

Tevogen Bio Holdings Inc

Market Cap

CLCS$37M

TVGN$29M

Enterprise Value

CLCS$48M

TVGN$29M

Price

CLCS$0.55

TVGN$6.78

P/E Ratio

CLCSN/A

TVGN6.23x

P/S Ratio

CLCS0.00x

TVGN0.00x

EV/Sales

CLCS0.00x

TVGN0.00x

EV/EBITDA

CLCS0.00x

TVGN0.00x

P/B Ratio

CLCSN/A

TVGNN/A

P/FCF Ratio

CLCSN/A

TVGNN/A

EV/FCF

CLCS-15.29x

TVGN-41.30x

PEG Ratio

CLCSN/A

TVGNN/A

Forward P/E (NTM)

CLCSN/A

TVGNN/A

Forward P/S (NTM)

CLCSN/A

TVGNN/A

Revenue (TTM)

CLCS$0

TVGN$0

Revenue Growth (YoY)

CLCSN/A

TVGNN/A

Forward Rev Growth

CLCS0.0%

TVGN0.0%

Gross Margin (TTM)

CLCS0.0%

TVGN0.0%

Operating Margin (TTM)

CLCS0.0%

TVGN0.0%

EBITDA Margin (TTM)

CLCS0.0%

TVGN0.0%

Net Margin (TTM)

CLCS0.0%

TVGN0.0%

FCF Margin (TTM)

CLCSN/A

TVGNN/A

Net Income (TTM)

CLCS$-6M

TVGN$3M

FCF (TTM)

CLCS$-3M

TVGN$-700K

EPS (TTM)

CLCS-$0.14

TVGN$1.09

ROE (TTM)

CLCS-184198.9%

TVGN0.0%

ROA (TTM)

CLCS-148238.0%

TVGN-46666.0%

ROIC (TTM)

CLCS0.0%

TVGN0.0%

Cash

CLCS$1K

TVGN$300K

Debt

CLCS$11M

TVGN$600K

Net Cash/Debt

CLCS$-10M

TVGN$-300K

Current Ratio (TTM)

CLCS0.01x

TVGN0.33x

Quick Ratio (TTM)

CLCS0.00x

TVGN0.20x

Debt/Equity (TTM)

CLCS0.00x

TVGN0.00x

Debt/Assets (TTM)

CLCS0.0%

TVGN0.0%

Interest Coverage (TTM)

CLCSN/A

TVGNN/A

Net Debt/EBITDA (TTM)

CLCS0.00x

TVGN0.00x

Beta

CLCS23.26

TVGN0.27

52W Performance

CLCS76.1%

TVGN-81.7%

YTD Performance

CLCS-9.1%

TVGN-62.7%

% from 52W High

CLCS-75.8%

TVGN-82.6%

% from 52W Low

CLCS199.8%

TVGN86.4%

Asset Turnover (TTM)

CLCS0.00x

TVGN0.00x

FCF Yield (TTM)

CLCS-8.4%

TVGN-2.4%

Earnings Yield (TTM)

CLCS-16.5%

TVGN11.8%

Dividend Yield (TTM)

CLCSN/A

TVGNN/A

Rule of 40

CLCS0.0

TVGN0.0

EV/GP/RG

CLCSN/A

TVGNN/A

Ticker research

View CLCS research View TVGN research

Metric	CLCS Cell Source Inc	TVGN Tevogen Bio Holdings Inc
Market & Valuation
Market Cap	$37M	$29M
Enterprise Value	$48M	$29M
Price	$0.55	$6.78
P/E Ratio	N/A	6.23x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-15.29x	-41.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$3M
FCF (TTM)	$-3M	$-700K
EPS (TTM)	-$0.14	$1.09
ROE (TTM)	-184198.9%	0.0%
ROA (TTM)	-148238.0%	-46666.0%
ROIC (TTM)	0.0%	0.0%
Financial Health
Cash	$1K	$300K
Debt	$11M	$600K
Net Cash/Debt	$-10M	$-300K
Current Ratio (TTM)	0.01x	0.33x
Quick Ratio (TTM)	0.00x	0.20x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	23.26	0.27
52W Performance	76.1%	-81.7%
YTD Performance	-9.1%	-62.7%
% from 52W High	-75.8%	-82.6%
% from 52W Low	199.8%	86.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-2.4%
Earnings Yield (TTM)	-16.5%	11.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLCS research	View TVGN research

Valuation

P/E Ratio

TVGN

6.23x

P/S Ratio

CLCS

0.00x

TVGN

0.00x

EV/FCF

TVGN

-41.30x

CLCS

-15.29x

Growth & revenue

Forward Revenue Growth

CLCS

0.0%

TVGN

0.0%

Profitability & performance

Gross Margin

CLCS

0.0%

TVGN

0.0%

ROE

TVGN

0.0%

CLCS

-184198.9%

FCF Yield %

TVGN

-2.4%

CLCS

-8.4%

52-Week Performance

CLCS

76.1%

TVGN

-81.7%

Detailed metrics comparison

CLCS

Cell Source Inc

TVGN

Tevogen Bio Holdings Inc

Market Cap

CLCS$37M

TVGN$29M

Enterprise Value

CLCS$48M

TVGN$29M

Price

CLCS$0.55

TVGN$6.78

P/E Ratio

CLCSN/A

TVGN6.23x

P/S Ratio

CLCS0.00x

TVGN0.00x

EV/Sales

CLCS0.00x

TVGN0.00x

EV/EBITDA

CLCS0.00x

TVGN0.00x

P/B Ratio

CLCSN/A

TVGNN/A

P/FCF Ratio

CLCSN/A

TVGNN/A

EV/FCF

CLCS-15.29x

TVGN-41.30x

PEG Ratio

CLCSN/A

TVGNN/A

Forward P/E (NTM)

CLCSN/A

TVGNN/A

Forward P/S (NTM)

CLCSN/A

TVGNN/A

Revenue (TTM)

CLCS$0

TVGN$0

Revenue Growth (YoY)

CLCSN/A

TVGNN/A

Forward Rev Growth

CLCS0.0%

TVGN0.0%

Gross Margin (TTM)

CLCS0.0%

TVGN0.0%

Operating Margin (TTM)

CLCS0.0%

TVGN0.0%

EBITDA Margin (TTM)

CLCS0.0%

TVGN0.0%

Net Margin (TTM)

CLCS0.0%

TVGN0.0%

FCF Margin (TTM)

CLCSN/A

TVGNN/A

Net Income (TTM)

CLCS$-6M

TVGN$3M

FCF (TTM)

CLCS$-3M

TVGN$-700K

EPS (TTM)

CLCS-$0.14

TVGN$1.09

ROE (TTM)

CLCS-184198.9%

TVGN0.0%

ROA (TTM)

CLCS-148238.0%

TVGN-46666.0%

ROIC (TTM)

CLCS0.0%

TVGN0.0%

Cash

CLCS$1K

TVGN$300K

Debt

CLCS$11M

TVGN$600K

Net Cash/Debt

CLCS$-10M

TVGN$-300K

Current Ratio (TTM)

CLCS0.01x

TVGN0.33x

Quick Ratio (TTM)

CLCS0.00x

TVGN0.20x

Debt/Equity (TTM)

CLCS0.00x

TVGN0.00x

Debt/Assets (TTM)

CLCS0.0%

TVGN0.0%

Interest Coverage (TTM)

CLCSN/A

TVGNN/A

Net Debt/EBITDA (TTM)

CLCS0.00x

TVGN0.00x

Beta

CLCS23.26

TVGN0.27

52W Performance

CLCS76.1%

TVGN-81.7%

YTD Performance

CLCS-9.1%

TVGN-62.7%

% from 52W High

CLCS-75.8%

TVGN-82.6%

% from 52W Low

CLCS199.8%

TVGN86.4%

Asset Turnover (TTM)

CLCS0.00x

TVGN0.00x

FCF Yield (TTM)

CLCS-8.4%

TVGN-2.4%

Earnings Yield (TTM)

CLCS-16.5%

TVGN11.8%

Dividend Yield (TTM)

CLCSN/A

TVGNN/A

Rule of 40

CLCS0.0

TVGN0.0

EV/GP/RG

CLCSN/A

TVGNN/A

Ticker research

View CLCS research View TVGN research

Metric	CLCS Cell Source Inc	TVGN Tevogen Bio Holdings Inc
Market & Valuation
Market Cap	$37M	$29M
Enterprise Value	$48M	$29M
Price	$0.55	$6.78
P/E Ratio	N/A	6.23x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-15.29x	-41.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$3M
FCF (TTM)	$-3M	$-700K
EPS (TTM)	-$0.14	$1.09
ROE (TTM)	-184198.9%	0.0%
ROA (TTM)	-148238.0%	-46666.0%
ROIC (TTM)	0.0%	0.0%
Financial Health
Cash	$1K	$300K
Debt	$11M	$600K
Net Cash/Debt	$-10M	$-300K
Current Ratio (TTM)	0.01x	0.33x
Quick Ratio (TTM)	0.00x	0.20x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	23.26	0.27
52W Performance	76.1%	-81.7%
YTD Performance	-9.1%	-62.7%
% from 52W High	-75.8%	-82.6%
% from 52W Low	199.8%	86.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-2.4%
Earnings Yield (TTM)	-16.5%	11.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLCS research	View TVGN research